BIOMAT Database Logo BIOMAT Database Logo

Long-term use of magnesium sulfate as a tocolytic agent. 1986

I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz

Two patients in premature labor were treated continuously for six and 13 weeks with intravenous magnesium sulfate (MgSO4) for tocolysis. In each case, conventional therapy with intravenous and oral ritodrine failed to abate uterine contractions, and attempts to taper the MgSO4 were unsuccessful. Both pregnancies proceeded uneventfully otherwise, with normal fetal growth. Long-term MgSO4 may be a safe and efficacious alternative for occasional patients not responding to other modes of therapy for the treatment of premature labor.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Magnesium sulfate as a tocolytic agent.
August 2001, Seminars in perinatology,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Magnesium sulfate as a tocolytic agent.
October 1983, American journal of obstetrics and gynecology,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Evidence for magnesium sulfate as a tocolytic agent.
October 1997, Obstetrical & gynecological survey,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery.
April 1982, American journal of obstetrics and gynecology,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
[Pros and cons of magnesium sulfate as a tocolytic].
January 2002, Akusherstvo i ginekologiia,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Perinatal death and tocolytic magnesium sulfate.
August 2000, Obstetrics and gynecology,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Magnesium sulfate: the first-line tocolytic.
September 2005, Obstetrics and gynecology clinics of North America,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Magnesium sulfate as a second-line tocolytic agent for preterm labor: a randomized controlled trial in Kyushu Island.
January 2011, Journal of pregnancy,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents.
September 1988, American journal of obstetrics and gynecology,
I A Wilkins, and J D Goldberg, and R N Phillips, and C J Bacall, and F A Chervenak, and R L Berkowitz
Tocolytic magnesium sulfate toxicity and unexpected neonatal death.
June 2001, Journal of perinatology : official journal of the California Perinatal Association,
Copied contents to your clipboard!